Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/1/2025

Guidelines for Starting Antihypertensive Treatment in People Over 60

Standard Treatment Threshold and Target

  • The American College of Physicians recommends initiating antihypertensive treatment when systolic blood pressure is persistently at or above 150 mmHg, targeting a systolic blood pressure of less than 150 mmHg to reduce mortality, stroke, and cardiac events (strong recommendation, high-quality evidence) 1, 2, 3, 4
  • This threshold applies to most adults aged 60 years or older without specific high-risk conditions 1
  • Treatment at this threshold reduces all-cause mortality (absolute risk reduction 1.64%), stroke (ARR 1.13%), and cardiac events (ARR 1.25%) 4
  • The greatest absolute benefit occurs in patients with baseline SBP >160 mmHg 4

Lower Targets for High-Risk Subgroups

  • Consider initiating or intensifying treatment to achieve SBP <140 mmHg in patients with a history of stroke or TIA (weak recommendation, moderate-quality evidence) 1, 2, 3, 4, 5
  • This lower target reduces risk of recurrent stroke 1, 2
  • Consider SBP target <140 mmHg based on individualized assessment for patients with high cardiovascular risk (weak recommendation, low-quality evidence) 1, 2, 3, 4

Pre-Treatment Requirements

  • Confirm persistently elevated blood pressure before initiating treatment 1, 2, 3, 4
  • Consider ambulatory blood pressure monitoring for patients with elevated clinic readings to rule out white coat hypertension 2, 3
  • Measure both systolic and diastolic blood pressure 1
  • Assess for orthostatic hypotension, particularly in patients ≥80 years 5
  • Evaluate cardiovascular risk factors and comorbid conditions 1, 6

Treatment Approach

  • Initiate or continue lifestyle modifications concurrently with pharmacologic treatment 2, 3, 4
  • Weight loss, DASH diet, and increased physical activity are effective non-pharmacologic options 4
  • First-line agents include thiazide-type diuretics, ACE inhibitors, ARBs, calcium-channel blockers 1, 5
  • Prescribe generic drugs where available 2, 3

Monitoring Schedule

  • Follow-up within first 2 months after initiating treatment to assess efficacy and tolerability 6, 5
  • Once target BP achieved, monitor every 3-6 months 6, 5

Important Caveats and Safety Considerations

  • Diastolic BP should optimally target 70-79 mmHg 5
  • Increased risk of cough, hypotension, and syncope with lower BP targets 2, 3
  • Electrolyte disturbances (hypokalemia, hyperkalemia, hyponatremia) 3
  • Acute kidney injury 3
  • Orthostatic hypotension 3
  • No increased risk of falls, fractures, or cognitive decline with treatment 2, 3
  • Select treatment goals based on periodic discussion of benefits and harms with the patient 1, 2, 3, 4
  • Balance cardiovascular risk reduction against treatment burden and potential adverse effects 1